Nucleic acids electrotransfer in vivo: Mechanisms and practical aspects

Current Gene Therapy

Volumn 10, Issue 4, 2010, Pages 267-280

  Andre, Franck M ^a,b   Mir, Lluis M ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

DNA injection; Electric pulses; Electropermeabilization; Electrophoresis; Electroporation; Minicircle; Plasmid

Indexed keywords

LIPOSOME; NUCLEIC ACID; POLYGLUTAMIC ACID; POLYMER; POVIDONE;

ARTICLE; CELL MEMBRANE; CELL PERMEABILIZATION; DRUG DISTRIBUTION; DRUG FORMULATION; ELECTRODE; ELECTROPHORESIS; ELECTROPORATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; IN VIVO GENE TRANSFER; IN VIVO STUDY; INFLAMMATION; NONHUMAN; SELF EVALUATION;

ANIMALS; BREAST NEOPLASMS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DNA; ELECTRODES; ELECTROPORATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; MELANOMA; MICE; RABBITS; RATS; RNA; SKIN NEOPLASMS; TISSUE DISTRIBUTION;

EID: 77958082492     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652310791823380     Document Type: Article

References (166)

1. Villemejane J, Mir LM. Physical methods of nucleic acid transfer: general concepts and applications. Br J Pharmacol 2009; 157(2): 207-19.
2. Favard C, Dean DS, Rols MP. Electrotransfer as a non viral method of gene delivery. Curr Gene Ther 2007; 7(1): 67-77.
3. Palazzoli F, Carnus E, Wells DJ, Bigot Y. Sustained transgene expression using non-viral enzymatic systems for stable chromosomal integration. Curr Gene Ther 2008; 8(5): 367-90.
4. Satkauskas S, Bureau MF, Puc M, et al. Mechanisms of in vivoDNA electrotransfer: respective contributions of cellelectropermeabilization and DNA electrophoresis. Mol Ther 2002; 5(2): 133-40.
5. Bureau MF, Gehl J, Deleuze V, Mir LM, Scherman D. Importanceof association between permeabilization and electrophoretic forcesfor intramuscular DNA electrotransfer. Biochim Biophys Acta 2000; 1474(3): 353-9.
6. Bureau MF, Naimi S, Torero Ibad R, et al. Intramuscular plasmidDNA electrotransfer: biodistribution and degradation. Biochim Biophys Acta 2004; 1676(2): 138-48.
7. Dupuis M, Denis-Mize K, Woo C, et al. Distribution of DNAvaccines determines their immunogenicity after intramuscularinjection in mice. J Immunol 2000; 165(5): 2850-8.
8. Davis HL, Whalen RG, Demeneix BA. Direct gene transfer intoskeletal muscle in vivo: factors affecting efficiency of transfer andstability of expression. Hum Gene Ther 1993; 4(2): 151-9.
9. Drabick JJ, Glasspool-Malone J, King A, Malone RW. Cutaneoustransfection and immune responses to intradermal nucleic acidvaccination are significantly enhanced by in vivo electropermeabilization. Mol Ther 2001; 3(2): 249-55.
10. Andre FM, Cournil-Henrionnet C, Vernerey D, Opolon P, Mir LM. Variability of naked DNA expression after direct local injection:the influence of the injection speed. Gene Ther 2006; 13(23): 1619-27.
11. Philipp A, Meyer M, Wagner E. Extracellular targeting of synthetictherapeutic nucleic acid formulations. Curr Gene Ther 2008; 8(5): 324-34.
12. Brunetti-Pierri N, Lee B. Gene therapy for inborn errors of livermetabolism. Mol Genet Metab 2005; 86(1-2): 13-24.
13. Wisse E, Jacobs F, Topal B, Frederik P, De Geest B. The size ofendothelial fenestrae in human liver sinusoids: implications forhepatocyte-directed gene transfer. Gene Ther 2008; 15(17): 1193-9.
14. Takakura Y, Mahato RI, Hashida M. Extravasation of macromolecules. Adv Drug Deliv Rev 1998; 34(1): 93-108.
15. Alexandrakis G, Brown EB, Tong RT, et al. Two-photonfluorescence correlation microscopy reveals the two-phase natureof transport in tumors. Nat Med 2004; 10(2): 203-7.
16. Netti PA, Berk DA, Swartz MA, Grodzinsky AJ, Jain RK. Role ofextracellular matrix assembly in interstitial transport in solidtumors. Cancer Res 2000; 60(9): 2497-503.
17. Pluen A, Boucher Y, Ramanujan S, et al. Role of tumor-hostinteractions in interstitial diffusion of macromolecules: cranial vs.subcutaneous tumors. Proc Natl Acad Sci U S A 2001; 98(8): 4628-33.
18. Ramanujan S, Pluen A, McKee TD, et al. Diffusion and convectionin collagen gels: implications for transport in the tumor interstitium. Biophys J 2002; 83(3): 1650-60.
19. Zaharoff DA, Barr RC, Li CY, Yuan F. Electromobility of plasmidDNA in tumor tissues during electric field-mediated gene delivery. Gene Ther 2002; 9(19): 1286-90.
20. Henshaw JW, Zaharoff DA, Mossop BJ, Yuan F. Electric fieldmediatedtransport of plasmid DNA in tumor interstitium in vivo. Bioelectrochemistry 2007; 71(2): 233-42.
21. Budker V, Budker T, Zhang G, Subbotin V, Loomis A, Wolff JA. Hypothesis: naked plasmid DNA is taken up by cells in vivo by areceptor-mediated process. J Gene Med 2000; 2(2): 76-88.
22. Golzio M, Teissie J, Rols MP. Direct visualization at the single-celllevel of electrically mediated gene delivery. Proc Natl Acad Sci US A 2002; 99(3): 1292-7.
23. Teissie J, Golzio M, Rols MP. Mechanisms of cell membraneelectropermeabilization: a minireview of our present (lack of?)knowledge. Biochim Biophys Acta 2005; 1724(3): 270-80.
24. Krassowska W, Filev PD. Modeling electroporation in a single cell. Biophys J 2007; 92(2): 404-17.
25. Smith KC, Neu JC, Krassowska W. Model of creation andevolution of stable electropores for DNA delivery. Biophys J 2004; 86(5): 2813-26.
26. Liu F, Heston S, Shollenberger LM, et al. Mechanism of in vivoDNA transport into cells by electroporation: electrophoresis acrossthe plasma membrane may not be involved. J Gene Med 2006; 8(3): 353-61.
27. Tarek M. Membrane electroporation: a molecular dynamicssimulation. Biophys J 2005; 88(6): 4045-53.
28. Eynard N, Rols MP, Ganeva V, et al. Electrotransformationpathways of prokaryotic and eukaryotic cells: recents developments. Bioelectrochem Bioenerg 1997; 44: 103-10.
29. Pavselj N, Preat V. DNA electrotransfer into the skin using acombination of one high-and one low-voltage pulse. J Control Release 2005; 106(3): 407-15.
30. Satkauskas S, Andre F, Bureau MF, et al. Electrophoreticcomponent of electric pulses determines the efficacy of in vivoDNA electrotransfer. Hum Gene Ther 2005; 16(10): 1194-201.
31. Andre FM, Gehl J, Sersa G, et al. Efficiency of high-and lowvoltagepulse combinations for gene electrotransfer in muscle,liver, tumor, and skin. Hum Gene Ther 2008; 19(11): 1261-71.
32. Mir LM, Bureau MF, Rangara R, Schwartz B, Scherman D. Longterm,high level in vivo gene expression after electric pulsemediatedgene transfer into skeletal muscle. C R Acad Sci III 1998; 321(11): 893-9.
33. Thyagarajan B, Olivares EC, Hollis RP, Ginsburg DS, Calos MP. Site-specific genomic integration in mammalian cells mediated byphage phiC31 integrase. Mol Cell Biol 2001; 21(12): 3926-34.
34. Hollis RP, Nightingale SJ, Wang X, et al. Stable gene transfer tohuman CD34(+) hematopoietic cells using the Sleeping Beautytransposon. Exp Hematol 2006; 34(10): 1333-43.
35. Bettan M, Emmanuel F, Darteil R, et al. High-level proteinsecretion into blood circulation after electric pulse-mediated genetransfer into skeletal muscle. Mol Ther 2000; 2(3): 204-10.
36. Tone CM, Cardoza DM, Carpenter RH, Draghia-Akli R. Long-termeffects of plasmid-mediated growth hormone releasing hormone indogs. Cancer Gene Ther 2004; 11(5): 389-96.
37. Mir LM, Bureau MF, Gehl J, et al. High-efficiency gene transferinto skeletal muscle mediated by electric pulses. Proc Natl Acad Sci U S A 1999; 96(8): 4262-7.
38. Reed SD, Li S. Electroporation Advances in Large Animals. Curr Gene Ther 2009; [Epub ahead of Print].
39. Gehl J, Skovsgaard T, Mir LM. Vascular reactions to in vivoelectroporation: characterization and consequences for drug andgene delivery. Biochim Biophys Acta 2002; 1569(1-3): 51-8.
40. Ramirez LH, Orlowski S, An D, et al. Electrochemotherapy onliver tumours in rabbits. Br J Cancer 1998; 77(12): 2104-11.
41. Sersa G, Cemazar M, Miklavcic D, Chaplin DJ. Tumor blood flowmodifying effect of electrochemotherapy with bleomycin. Anticancer Res 1999; 19(5B): 4017-22.
42. Sersa G, Cemazar M, Parkins CS, Chaplin DJ. Tumour blood flowchanges induced by application of electric pulses. Eur J Cancer 1999; 35(4): 672-7.
43. Sersa G, Jarm T, Kotnik T, et al. Vascular disrupting action ofelectroporation and electrochemotherapy with bleomycin in murinesarcoma. Br J Cancer 2008; 98(2): 388-98.
44. Takeshita S, Isshiki T, Sato T. Increased expression of direct genetransfer into skeletal muscles observed after acute ischemic injuryin rats. Lab Invest 1996; 74(6): 1061-5.
45. Marty M, Sersa G, Garbay JR, et al. Electrochemotherapy - Aneasy, highly effective and safe treatment of cutaneous andsubcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl 2006; 4: 3-13.
46. Hojman P, Gissel H, Andre FM, et al. Physiological effects ofhigh-and low-voltage pulse combinations for gene electrotransferin muscle. Hum Gene Ther 2008; 19(11): 1249-60.
47. Gissel H. Effects of varying pulse parameters on ion homeostasis,cellular integrity, and force following electroporation of rat musclein vivo. Am J Physiol Regul Integr Comp Physiol 2010.
48. Liu J, Kjeken R, Mathiesen I, Barouch DH. Recruitment ofantigen-presenting cells to the site of inoculation and augmentationof human immunodeficiency virus type 1 DNA vaccineimmunogenicity by in vivo electroporation. J Virol 2008; 82(11): 5643-9.
49. Scheerlinck JP, Karlis J, Tjelle TE, Presidente PJ, Mathiesen I.Newton SE. In vivo electroporation improves immune responses toDNA vaccination in sheep. Vaccine 2004; 22(13-14): 1820-5.
50. Bromberg JS, Debruyne LA, Qin L. Interactions between theimmune system and gene therapy vectors: bidirectional regulationof response and expression. Adv Immunol 1998; 69: 353-409.
51. Mir LM, Moller PH, Andre F, Gehl J. Electric pulse-mediated genedelivery to various animal tissues. Adv Genet 2005; 54: 83-114.
52. Aung W, Hasegawa S, Koshikawa-Yano M, et al. Visualization ofin vivo electroporation-mediated transgene expression in experimentaltumors by optical and magnetic resonance imaging. Gene Ther 2009; 16(7): 830-9.
53. DiFranco M, Quinonez M, Capote J, Vergara J. DNA transfectionof mammalian skeletal muscles using in vivo electroporation. J Vis Exp 2009; (32).
54. Boutin C, Diestel S, Desoeuvre A, Tiveron MC, Cremer H. Efficient in vivo electroporation of the postnatal rodent forebrain. PLoS One 2008; 3(4): e1883.
55. Martel-Renoir D, Trochon-Joseph V, Galaup A, et al. Coelectrotransfer to skeletal muscle of three plasmids coding forantiangiogenic factors and regulatory factors of the tetracyclineinduciblesystem: tightly regulated expression, inhibition oftransplanted tumor growth, and antimetastatic effect. Mol Ther 2003; 8(3): 425-33.
56. Hickman MA, Malone RW, Lehmann-Bruinsma K, et al. Geneexpression following direct injection of DNA into liver. Hum Gene Ther 1994; 5(12): 1477-83.
57. Mahato RI, Takakura Y, Hashida M. Nonviral vectors for in vivogene delivery: physicochemical and pharmacokinetic considerations. Crit Rev Ther Drug Carrier Syst 1997; 14(2): 133-72.
58. Sakai M, Nishikawa M, Thanaketpaisarn O, Yamashita F, Hashida M. Hepatocyte-targeted gene transfer by combination of vascularlydelivered plasmid DNA and in vivo electroporation. Gene Ther 2005; 12(7): 607-16.
59. Liu F, Huang L. Electric gene transfer to the liver followingsystemic administration of plasmid DNA. Gene Ther 2002; 9(16): 1116-9.
60. Sheu E, Rothman S, German M, et al. The Gene Pill and itstherapeutic applications. Curr Opin Mol Ther 2003; 5(4): 420-7.
61. Rothman S, Tseng H, Goldfine I. Oral gene therapy: a novelmethod for the manufacture and delivery of protein drugs. Diabetes Technol Ther 2005; 7(3): 549-57.
62. Sakamoto T, Miyazaki E, Aramaki Y, et al. Improvement ofdermatitis by iontophoretically delivered antisense oligonucleotidesfor interleukin-10 in NC/Nga mice. Gene Ther 2004; 11(3): 317-24.
63. Davies JB, Ciavatta VT, Boatright JH, Nickerson JM. Delivery ofseveral forms of DNA, DNA-RNA hybrids, and dyes across humansclera by electrical fields. Mol Vis 2003; 9: 569-78.
64. Hao J, Li SK, Liu CY, Kao WW. Electrically assisted delivery ofmacromolecules into the corneal epithelium. Exp Eye Res 2009; 89(6): 934-41.
65. Vandermeulen G, Staes E, Vanderhaeghen ML, et al. Optimisationof intradermal DNA electrotransfer for immunisation. J Control Release 2007; 124(1-2): 81-7.
66. Densmore CL. Advances in noninvasive pulmonary gene therapy. Curr Drug Deliv 2006; 3(1): 55-63.
67. Zhou R, Norton JE, Dean DA. Electroporation-mediated genedelivery to the lungs. Methods Mol Biol 2008; 423: 233-47.
68. Karim S, Troiano E, Mather TN. Functional genomics tool: Genesilencing in Ixodes scapularis eggs and nymphs by electroporateddsRNA. BMC Biotechnol 2010; 10(1): 1.
69. Kato Y, Kobayashi K, Watanabe H, Iguchi T. Introduction offoreign DNA into the water flea, Daphnia magna, by electroporation. Ecotoxicology 2010; 19(3): 589-92.
70. Cemazar M, Golzio M, Sersa G, et al. Control by pulse parametersof DNA electrotransfer into solid tumors in mice. Gene Ther 2009; 16(5): 635-44.
71. Levy MY, Barron LG, Meyer KB, Szoka FC, Jr. Characterizationof plasmid DNA transfer into mouse skeletal muscle: evaluation ofuptake mechanism, expression and secretion of gene products intoblood. Gene Ther 1996; 3(3): 201-11.
72. Wolff JA, Williams P, Acsadi G, Jiao S, Jani A, Chong W. Conditions affecting direct gene transfer into rodent muscle in vivo. Biotechniques 1991; 11(4): 474-85.
73. Manthorpe M, Cornefert-Jensen F, Hartikka J, et al. Gene therapyby intramuscular injection of plasmid DNA: studies on fireflyluciferase gene expression in mice. Hum Gene Ther 1993; 4(4): 419-31.
74. Anwer K. Formulations for DNA delivery via electroporation invivo. Methods Mol Biol 2008; 423: 77-89.
75. Fewell JG, MacLaughlin F, Mehta V, et al. Gene therapy for thetreatment of hemophilia B using PINC-formulated plasmiddelivered to muscle with electroporation. Mol Ther 2001; 3(4): 574-83.
76. Draghia-Akli R, Khan AS, Cummings KK, et al. Electricalenhancement of formulated plasmid delivery in animals. Technol Cancer Res Treat 2002; 1(5): 365-72.
77. Nicol F, Wong M, MacLaughlin FC, et al. Poly-L-glutamate, ananionic polymer, enhances transgene expression for plasmidsdelivered by intramuscular injection with in vivo electroporation. Gene Ther 2002; 9(20): 1351-8.
78. Quaglino E, Iezzi M, Mastini C, et al. Electroporated DNA vaccineclears away multifocal mammary carcinomas in her-2/neutransgenic mice. Cancer Res 2004; 64(8): 2858-64.
79. Spadaro M, Ambrosino E, Iezzi M, et al. Cure of mammarycarcinomas in Her-2 transgenic mice through sequential stimulationof innate (neoadjuvant interleukin-12) and adaptive (DNA vaccineelectroporation) immunity. Clin Cancer Res 2005; 11(5): 1941-52.
80. Fujii T, Suzuki T, Fujii M, et al. Inhibition of microtubuleassembly by poly(L-glutamic acid) and the site of its action. Biochem Cell Biol 1986; 64(7): 615-21.
81. Maurer PH. Antigenicity of polypeptides (poly-alpha-amino acids).XVII. Immunologic studies in humans with polymers containing Lor D and L-alpha-amino acids. J Immunol 1965; 95(6): 1095-9.
82. Riera M, Chillon M, Aran JM, et al. Intramuscular SP1017-formulated DNA electrotransfer enhances transgene expression anddistributes hHGF to different rat tissues. J Gene Med 2004; 6(1): 111-8.
83. Lemieux P, Guerin N, Paradis G, et al. A combination of poloxamersincreases gene expression of plasmid DNA in skeletal muscle. Gene Ther 2000; 7(11): 986-91.
84. Mumper RJ, Wang J, Klakamp SL, et al. Protective interactivenoncondensing (PINC) polymers for enhanced plasmid distributionand expression in rat skeletal muscle. J Control Release 1998; 52(1-2): 191-203.
85. Mendiratta SK, Thai G, Eslahi NK, et al. Therapeutic tumorimmunity induced by polyimmunization with melanoma antigensgp100 and TRP-2. Cancer Res 2001; 61(3): 859-63.
86. Wells JM, Li LH, Sen A, Jahreis GP, Hui SW. Electroporationenhancedgene delivery in mammary tumors. Gene Ther 2000; 7(7): 541-7.
87. Cemazar M, Sersa G, Wilson J, et al. Effective gene transfer tosolid tumors using different nonviral gene delivery techniques:electroporation, liposomes, and integrin-targeted vector. Cancer Gene Ther 2002; 9(4): 399-406.
88. Kawata Y, Yano S, Kojima H, Toyomizu M. Transformation ofSpirulina platensis strain C1 (Arthrospira sp. PCC9438) with Tn5transposase-transposon DNA-cation liposome complex. Mar Biotechnol (NY) 2004; 6(4): 355-63.
89. Machy P, Lewis F, McMillan L, Jonak ZL. Gene transfer fromtargeted liposomes to specific lymphoid cells by electroporation. Proc Natl Acad Sci U S A 1988; 85(21): 8027-31.
90. Mennuni C, Calvaruso F, Zampaglione I, et al. Hyaluronidaseincreases electrogene transfer efficiency in skeletal muscle. Hum Gene Ther 2002; 13(3): 355-65.
91. McMahon JM, Signori E, Wells KE, Fazio VM, Wells DJ. Optimisation of electrotransfer of plasmid into skeletal muscle bypretreatment with hyaluronidase--increased expression withreduced muscle damage. Gene Ther 2001; 8(16): 1264-70.
92. Molnar MJ, Gilbert R, Lu Y, et al. Factors influencing the efficacy,longevity, and safety of electroporation-assisted plasmid-basedgene transfer into mouse muscles. Mol Ther 2004; 10(3): 447-55.
93. Schertzer JD, Plant DR, Lynch GS. Optimizing plasmid-based genetransfer for investigating skeletal muscle structure and function. Mol Ther 2006; 13(4): 795-803.
94. Evans V, Foster H, Graham IR, et al. Human apolipoprotein Eexpression from mouse skeletal muscle by electrotransfer ofnonviral DNA (plasmid) and pseudotyped recombinant adenoassociatedvirus (AAV2/7). Hum Gene Ther 2008; 19(6): 569-78.
95. Henshaw J, Mossop B, Yuan F. Relaxin treatment of solid tumors:effects on electric field-mediated gene delivery. Mol Cancer Ther 2008; 7(8): 2566-73.
96. Lee MJ, Cho SS, Jang HS, et al. Optimal salt concentration ofvehicle for plasmid DNA enhances gene transfer mediated byelectroporation. Exp Mol Med 2002; 34(4): 265-72.
97. Chesnoy S, Huang L. Enhanced cutaneous gene delivery followingintradermal injection of naked DNA in a high ionic strengthsolution. Mol Ther 2002; 5(1): 57-62.
98. 2+ on invivo gene transfer by electroporation. Acta Pharmacol Sin 2006; 27(3): 307-10.
99. 2concentration on the rate of foreign gene transfer and expression byin vivo electroporation in the mouse ovary. Int J Mol Med 2003; 12(3): 365-8.
100. Glasspool-Malone J, Malone RW. Marked enhancement of directrespiratory tissue transfection by aurintricarboxylic acid. Hum Gene Ther 1999; 10(10): 1703-13.
101. Glasspool-Malone J, Steenland PR, McDonald RJ, et al. DNAtransfection of macaque and murine respiratory tissue is greatlyenhanced by use of a nuclease inhibitor. J Gene Med 2002; 4(3): 323-2.
102. Glasspool-Malone J, Somiari S, Drabick JJ, Malone RW. Efficientnonviral cutaneous transfection. Mol Ther 2000; 2(2): 140-6.
103. Walther W, Stein U, Fichtner I, et al. Nonviral jet-injection genetransfer for efficient in vivo cytosine deaminase suicide genetherapy of colon carcinoma. Mol Ther 2005; 12(6): 1176-84.
104. Glasspool-Malone J, Malone RW. Enhancing direct in vivotransfection with nuclease inhibitors and pulsed electrical fields. Methods Enzymol 2002; 346: 72-91.
105. Paganin-Gioanni A, Bellard E, Couderc B, Teissie J, Golzio M. Tracking in vitro and in vivo siRNA electrotransfer in tumor cells. JRNAi Gene Silencing 2008; 4(1): 281-8.
106. Miklavcic D, Corovic S, Pucihar G, Pavselj N. Importance oftumour coverage by sufficiently high local electric field foreffective electrochemotherapy. Eur J Cancer Suppl 2006; 4: 45-51.
107. Mir LM, Gehl J, Sersa G, et al. Standard operating procedures ofthe electrochemotherapy: Instructions for the use of bleomycin orcisplatin administered either systemically or locally and electricpulses delivered by the Cliniporator TM by means of invasive ornon-invasive electrodes. Eur J Cancer Suppl 2006; 4: 14-25.
108. Saulis G, Lape R, Praneviciute R, Mickevicius D. Changes of thesolution pH due to exposure by high-voltage electric pulses. Bioelectrochemistry 2005; 67(1): 101-8.
109. Tomov T, Tsoneva I. Are the stainless steel electrodes inert?Bioelectrochemistry 2000; 51(2): 207-9.
110. Kim HB, Ahn S, Jang HJ, Sim SB, Kim KW. Evaluation ofcorrosion behaviors and surface profiles of platinum-coatedelectrodes by electrochemistry and complementary microscopy:biomedical implications for anticancer therapy. Micron 2007; 38(7): 747-53.
111. Miklavcic D, Semrov D, Mekid H, Mir LM. A validated model ofin vivo electric field distribution in tissues for electrochemotherapyand for DNA electrotransfer for gene therapy. Biochim Biophys Acta 2000; 1523(1): 73-83.
112. Sel D, Mazeres S, Teissie J, Miklavcic D. Finite-element modelingof needle electrodes in tissue from the perspective of frequentmodel computation. IEEE Trans Biomed Eng 2003; 50(11): 1221-32.
113. Gehl J, Sorensen TH, Nielsen K, et al. In vivo electroporation ofskeletal muscle: threshold, efficacy and relation to electric fielddistribution. Biochim Biophys Acta 1999; 1428(2-3): 233-40.
114. Corovic S, Al Sakere B, Haddad V, Miklavcic D, Mir LM. Importance of contact surface between electrodes and treated tissuein electrochemotherapy. Technol Cancer Res Treat 2008; 7(5): 393-400.
115. Ivorra A, Al-Sakere B, Rubinsky B, Mir LM. Use of conductivegels for electric field homogenization increases the antitumorefficacy of electroporation therapies. Phys Med Biol 2008; 53(22): 6605-18.
116. Sel D, Cukjati D, Batiuskaite D, et al. Sequential finite elementmodel of tissue electropermeabilization. IEEE Trans Biomed Eng 2005; 52(5): 816-27.
117. Rabussay D. Applicator and electrode design for in vivo DNAdelivery by electroporation. Methods Mol Biol 2008; 423: 35-59.
118. Suzuki T, Shin BC, Fujikura K, Matsuzaki T, Takata K. Directgene transfer into rat liver cells by in vivo electroporation. FEBSLett 1998; 425(3): 436-40.
119. Ostapenko OV, Boitsov AS, Baranov AN, et al. Dependence of theefficacy of transfecting muscle fibers in vivo on electroporationconditions. Genetika 2004; 40(1): 41-8.
120. Cukjati D, Batiuskaite D, Andre F, Miklavcic D, Mir LM. Realtime electroporation control for accurate and safe in vivo non-viralgene therapy. Bioelectrochemistry 2007; 70(2): 501-7.
121. Draghia-Akli R, Ellis KM, Hill LA, Malone PB, Fiorotto ML. High-efficiency growth hormone-releasing hormone plasmid vectoradministration into skeletal muscle mediated by electroporation inpigs. FASEB J 2003; 17(3): 526-8.
122. Corovic S, Pavlin M, Miklavcic D. Analytical and numericalquantification and comparison of the local electric field in thetissue for different electrode configurations. Biomed Eng Online 2007; 6: 37.
123. Gilbert RA, Jaroszeski MJ, Heller R. Novel electrode designs forelectrochemotherapy. Biochim Biophys Acta 1997; 1334(1): 9-14.
124. Choi SO, Kim YC, Park JH, et al. An electrically activemicroneedle array for electroporation. Biomed Microdevices 2009; 12(2): 263-73.
125. Faurie C, Phez E, Golzio M, et al. Effect of electric fieldvectoriality on electrically mediated gene delivery in mammaliancells. Biochim Biophys Acta 2004; 1665(1-2): 92-100.
126. Rebersek M, Faurie C, Kanduser M, et al. Electroporator withautomatic change of electric field direction improves geneelectrotransfer in-vitro. Biomed Eng Online 2007; 6: 25.
127. Liu F, Huang L. A syringe electrode device for simultaneousinjection of DNA and electrotransfer. Mol Ther 2002; 5(3): 323-8.
128. Tjelle TE, Salte R, Mathiesen I, Kjeken R. A novel electroporationdevice for gene delivery in large animals and humans. Vaccine 2006; 24(21): 4667-70.
129. Martin JB, Young JL, Benoit JN, Dean DA. Gene transfer to intactmesenteric arteries by electroporation. J Vasc Res 2000; 37(5): 372-80.
130. Soden D, Larkin J, Collins C, et al. The development of novelflexible electrode arrays for the electrochemotherapy of solidtumour tissue. (Potential for endoscopic treatment of inaccessiblecancers). Conf Proc IEEE Eng Med Biol Soc 2004; 5: 3547-50.
131. Soden DM, Larkin JO, Collins CG, et al. Successful application oftargeted electrochemotherapy using novel flexible electrodes andlow dose bleomycin to solid tumours. Cancer Lett 2006; 232(2): 300-10.
132. Ball C, Thomson KR, Kavnoudias H. Irreversible Electroporation:A New Challenge in "Out of Operating Theater" Anesthesia. Anesth Analg 2010; 110(5): 1305-9.
133. Mazeres S, Sel D, Golzio M, et al. Non invasive contact electrodesfor in vivo localized cutaneous electropulsation and associated drugand nucleic acid delivery. J Control Release 2009; 134(2): 125-31.
134. Heller R, Cruz Y, Heller LC, Gilbert RA, Jaroszeski MJ. Electrically Mediated Delivery of Plasmid DNA to the Skin, Usinga Multielectrode Array. Hum Gene Ther 2010; 21(3): 357-62.
135. Pliquett U, Weaver JC. Feasibility of an electrode-reservoir devicefor transdermal drug delivery by noninvasive skin electroporation. IEEE Trans Biomed Eng 2007; 54(3): 536-8.
136. Bestman JE, Ewald RC, Chiu SL, Cline HT. In vivo single-cellelectroporation for transfer of DNA and macromolecules. Nat Protoc 2006; 1(3): 1267-72.
137. Chen C, Evans JA, Robinson MP, Smye SW, O'Toole P. Electroporation of cells using EM induction of ac fields by amagnetic stimulator. Phys Med Biol 2010; 55(4): 1219-29.
138. Draghia-Akli R, Khan AS, Brown PA, et al. Parameters for DNAvaccination using adaptive constant-current electroporation inmouse and pig models. Vaccine 2008; 26(40): 5230-7.
139. Pavlin D, Tozon N, Sersa G, Pogacnik A, Cemazar M. Efficientelectrotransfection into canine muscle. Technol Cancer Res Treat 2008; 7(1): 45-54.
140. Faurie C, Golzio M, Moller P, Teissie J, Rols MP. Cell and animalimaging of electrically mediated gene transfer. DNA Cell Biol 2003; 22(12): 777-83.
141. Cemazar M, Pavlin D, Kranjc S, et al. Sequence and timedependence of transfection efficiency of electrically-assisted genedelivery to tumors in mice. Curr Drug Deliv 2006; 3(1): 77-81.
142. Mesojednik S, Pavlin D, Sersa G, et al. The effect of thehistological properties of tumors on transfection efficiency ofelectrically assisted gene delivery to solid tumors in mice. Gene Ther 2007; 14(17): 1261-9.
143. Boutin C, Hardt O, de Chevigny A, et al. Neuro D1 inducesterminal neuronal differentiation in olfactory neurogenesis. Proc Natl Acad Sci U S A 2010; 107(3): 1201-6.
144. Medi BM, Singh J. Skin targeted DNA vaccine delivery usingelectroporation in rabbits II. Safety. Int J Pharm 2006; 308(1-2): 61-8.
145. Doh ST, Hao H, Loh SC, et al. Analysis of retinal cell developmentin chick embryo by immunohistochemistry and in ovoelectroporation techniques. BMC Dev Biol 2010; 10(1): 8.
146. Brown PA, Davis WC, Draghia-Akli R. Immune-enhancing effectsof growth hormone-releasing hormone delivered by plasmidinjection and electroporation. Mol Ther 2004; 10(4): 644-51.
147. Khan AS, Smith LC, Abruzzese RV, et al. Optimization ofelectroporation parameters for the intramuscular delivery ofplasmids in pigs. DNA Cell Biol 2003; 22(12): 807-14.
148. Matsuki N, Ishikawa T, Imai Y, Yamaguchi T. Low voltage pulsescan induce apoptosis. Cancer Lett 2008; 269(1): 93-100.
149. Block TA, Aarsvold JN, Matthews KL, 2nd, et al. The 1995Lindberg Award. Nonthermally mediated muscle injury andnecrosis in electrical trauma. J Burn Care Rehabil 1995; 16(6): 581-8.
150. Hartikka J, Sukhu L, Buchner C, et al. Electroporation-facilitateddelivery of plasmid DNA in skeletal muscle: plasmid dependenceof muscle damage and effect of poloxamer 188. Mol Ther 2001; 4(5): 407-15.
151. Gehl J, Geertsen PF. Efficient palliation of haemorrhagingmalignant melanoma skin metastases by electrochemotherapy. Melanoma Res 2000; 10(6): 585-9.
152. Wallace M, Evans B, Woods S, et al. Tolerability of two sequentialelectroporation treatments using Med Pulser DNA delivery system(DDS) in healthy adults. Mol Ther 2009; 17(5): 922-8.
153. Heller R, Jaroszeski M, Atkin A, et al. In vivo gene electroinjectionand expression in rat liver. FEBS Lett 1996; 389(3): 225-8.
154. Gehl J. Electroporation for drug and gene delivery in the clinic:doctors go electric. Methods Mol Biol 2008; 423: 351-9.
155. Mali B, Jarm T, Corovic S, et al. The effect of electroporationpulses on functioning of the heart. Med Biol Eng Comput 2008; 46(8): 745-57.
156. Darquet AM, Rangara R, Kreiss P, et al. Minicircle: an improvedDNA molecule for in vitro and in vivo gene transfer. Gene Ther 1999; 6(2): 209-18.
157. Schleef M, Blaesen M. Production of plasmid DNA as apharmaceutical. Methods Mol Biol 2009; 542: 471-95.
158. Mayrhofer P, Schleef M, Jechlinger W. Use of minicircle plasmidsfor gene therapy. Methods Mol Biol 2009; 542: 87-104.
159. Ivorra A, Al-Sakere B, Rubinsky B, Mir LM. In vivo electricalconductivity measurements during and after tumor electroporation:conductivity changes reflect the treatment outcome. Phys Med Biol 2009; 54(19): 5949-63.
160. Granot Y, Ivorra A, Maor E, Rubinsky B. In vivo imaging ofirreversible electroporation by means of electrical impedancetomography. Phys Med Biol 2009; 54(16): 4927-43.
161. Andre F, Mir LM. DNA electrotransfer: its principles and anupdated review of its therapeutic applications. Gene Ther 2004; 11Suppl 1: S33-42.
162. Cemazar M, Sersa G. Electrotransfer of therapeutic molecules intotissues. Curr Opin Mol Ther 2007; 9(6): 554-62.
163. Guan X, Nishikawa M, Takemoto S, et al. Injection site-dependentinduction of immune response by DNA vaccine: comparison ofskin and spleen as a target for vaccination. J Gene Med 2010; 12(3): 301-9.
164. Luxembourg A, Evans CF, Hannaman D. Electroporation-basedDNA immunisation: translation to the clinic. Expert Opin Biol Ther 2007; 7(11): 1647-64.
165. Bodles-Brakhop AM, Heller R, Draghia-Akli R. Electroporationfor the delivery of DNA-based vaccines and immunotherapeutics:current clinical developments. Mol Ther 2009; 17(4): 585-92.
166. Daud AI, DeConti RC, Andrews S, et al. Phase I trial ofinterleukin-12 plasmid electroporation in patients with metastaticmelanoma. J Clin Oncol 2008; 26(36): 5896-903.